Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Splice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function.
PMID 41771836 · PMC13039997 · Cell death & disease · 2026 · 7 claims · 8 setups
BCS1L is alternatively spliced into a full-length isoform (BCS1L-L) and an exon 2-skipped short isoform (BCS1L-S)
-
Full-text index only
Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer.
PMID 18690643 · PMC3970323 · Proteomics · 2008 · 8 claims · 5 setups
N-linked glycan biosynthetic enzyme transcript profiles in normal mouse and human ovarian tissue are similar, indicating species conservation
-
Full-text index only
Comparative transcriptome analysis of two pomelo accessions with different parthenocarpic ability provides insight into the molecular mechanisms of parthenocarpy in pomelo (Citrus grandis).
PMID 39135650 · PMC11317442 · Frontiers in plant science · 2024 · 6 claims · 6 setups
G pomelo exhibits significantly higher parthenocarpic ability (ovary growth, cell division, fruit setting) than S pomelo following emasculation
-
Full-text index only
Single-cell dissection of regulated cell death dynamics in ovarian aging.
PMID 41689119 · PMC13005338 · Journal of ovarian research · 2026 · 8 claims · 8 setups
The RCD landscape of ovarian aging had not previously been characterized at single-cell resolution
-
Full-text index only
A transcriptomic-based model associated with PARP inhibitor sensitivity and immunogenic signatures in ovarian cancer.
PMID 42014663 · PMC13230468 · Discover oncology · 2026 · 8 claims · 8 setups
A 23-gene PARPi-sensor transcriptomic model stratifies ovarian cancer patients into high- and low-risk groups with significantly different overall survival, validated in TCGA and ICGC cohorts